Introduction:
The biosimilar market in India is rapidly growing, with several emerging startups making their mark in the industry. As of 2026, the biosimilar sector in India is witnessing significant growth, with a focus on innovation and affordability. According to recent reports, the biosimilar market in India is expected to reach a production volume of over 100 million units by the end of the year.
Top 10 Emerging Biosimilar Startups in India 2026:
1. Biocon Limited
Biocon Limited is a leading biopharmaceutical company in India, specializing in biosimilars. With a market share of over 30%, Biocon is a key player in the biosimilar market, producing a wide range of high-quality and affordable biosimilar products.
2. Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories is another prominent player in the biosimilar industry in India. With a production volume of over 50 million units, Dr. Reddy’s is known for its cutting-edge research and development in biosimilar products.
3. Lupin Limited
Lupin Limited is a pharmaceutical company that has been making significant strides in the biosimilar market. With a market share of 15%, Lupin is known for its innovative biosimilar products that cater to a wide range of therapeutic areas.
4. Intas Pharmaceuticals
Intas Pharmaceuticals is a fast-growing biosimilar startup in India, with a focus on producing high-quality and cost-effective biosimilar products. Intas has seen a steady increase in its market share over the past few years, making it a key player in the biosimilar industry.
5. Cadila Healthcare
Cadila Healthcare is a leading pharmaceutical company in India, with a strong presence in the biosimilar market. With a production volume exceeding 40 million units, Cadila Healthcare is known for its commitment to innovation and quality in biosimilar products.
6. Sun Pharmaceutical Industries
Sun Pharmaceutical Industries is a well-established player in the biosimilar market in India. With a market share of 20%, Sun Pharma is known for its wide range of biosimilar products that cater to various therapeutic areas, including oncology and autoimmune diseases.
7. Cipla Limited
Cipla Limited is a renowned pharmaceutical company in India, with a growing presence in the biosimilar market. With a production volume of over 30 million units, Cipla is known for its high-quality and affordable biosimilar products that meet international standards.
8. Glenmark Pharmaceuticals
Glenmark Pharmaceuticals is a key player in the biosimilar industry in India, with a strong focus on research and development. With a market share of 10%, Glenmark is known for its innovative biosimilar products that address critical unmet medical needs.
9. Aurobindo Pharma
Aurobindo Pharma is a leading pharmaceutical company in India, with a significant presence in the biosimilar market. With a production volume exceeding 50 million units, Aurobindo Pharma is known for its high-quality biosimilar products that are both effective and affordable.
10. Torrent Pharmaceuticals
Torrent Pharmaceuticals is a growing player in the biosimilar industry in India, with a focus on producing high-quality and cost-effective biosimilar products. With a market share of 5%, Torrent Pharmaceuticals is steadily gaining momentum in the biosimilar market.
Insights:
The biosimilar market in India is set to witness robust growth in the coming years, driven by factors such as increasing healthcare expenditure, rising demand for affordable treatment options, and a growing focus on research and development. According to industry reports, the biosimilar market in India is expected to grow at a CAGR of 15% over the next five years, reaching a market size of USD 3 billion by 2030. With the emergence of new startups and the entry of established players into the market, the biosimilar industry in India is poised for significant expansion and innovation.
Related Analysis: View Previous Industry Report
